O. Ashiru

发表

Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands*

J. Skepper, H. Reyburn, M. Valés‐Gómez, 2010, The Journal of Biological Chemistry.

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.

J. Skepper, H. Reyburn, M. Valés‐Gómez, 2010, Cancer research.

The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells

H. Reyburn, M. Valés‐Gómez, Lola Fernández-Messina, 2011, Journal of Cell Science.

The human NKG 2 D ligand ULBP 2 can be expressed at the cell surface either with or without a GPI anchor and both forms can activate NK cells

H. Reyburn, M. Valés‐Gómez, Lola Fernández-Messina, 2010 .

Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores.

T. Butters, O. Ashiru, J. D. Howe, 2014, Virology.

Natural killer activation for bladder cancer elimination can be achieved in vitro by heat-killed BCG

E. Julián, Carlos Martín, N. Aguiló, 2020, bioRxiv.

Intracellular Sequestration of the NKG2D Ligand ULBP3 by Human Cytomegalovirus

J. Trowsdale, M. Wills, J. Sissons, 2010, The Journal of Immunology.

Ligand ULBP3 by Human Cytomegalovirus Intracellular Sequestration of the NKG2D

J. Trowsdale, M. Wills, R. Eagle, 2010 .

Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes

Eva M García-Cuesta, M. Álvarez-Maestro, L. Martínez-Piñeiro, 2017, Oncoimmunology.

A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.

H. Reyburn, Lola Fernández-Messina, O. Ashiru, 2013, The Biochemical journal.

Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding

Eric O Long, C. Gross, H. Reyburn, 2011, European journal of immunology.

Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence

R. Cowan, J. Galson, W. Lee, 2020, bioRxiv.

Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG

E. Julián, Carlos Martín, N. Aguiló, 2021, Frontiers in Immunology.

BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine

Eva M García-Cuesta, M. Álvarez-Maestro, L. Martínez-Piñeiro, 2019, Cancers.

Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses

J. Galson, W. Lee, P. Pfeffer, 2021, Frontiers in Immunology.

Development of a custom pentaplex sandwich immunoassay using Protein-G coupled beads for the Luminex® xMAP® platform.

J. Ekeruche-Makinde, J. Tregoning, J. U. McDonald, 2016, Journal of immunological methods.

Human Cytomegalovirus Encodes an MHC Class I-Like Molecule (UL142) That Functions to Inhibit NK Cell Lysis1

J. Trowsdale, P. Tomasec, G. Wilkinson, 2005, The Journal of Immunology.

NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142

Mair E. M. Thomas, J. Trowsdale, M. Wills, 2009, Journal of Virology.

Viral strategies to modulate NKG2D-ligand expression in Human Cytomegalovirus infection

H. Reyburn, O. Ashiru, G. Esteso, 2016 .

NKG 2 D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL 142

Mair E. M. Thomas, J. Trowsdale, M. Wills, 2009 .

Regulation of NKG2D ligand gene expression.

J. Trowsdale, M. Wills, J. Traherne, 2006, Human immunology.

Functions to Inhibit NK Cell Lysis Class I-Like Molecule (UL142) That Human Cytomegalovirus Encodes an MHC

J. Trowsdale, P. Tomasec, M. Wills, 2005 .

Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes

Eva M García-Cuesta, M. Álvarez-Maestro, L. Martínez-Piñeiro, 2017, Oncoimmunology.